Untargeted metabolomics analysis of esophageal squamous cell cancer progression

90% of esophageal cancer are esophageal squamous cell carcinoma (ESCC) and ESCC has a very poor prognosis and high mortality. Nevertheless, the key metabolic pathways associated with ESCC progression haven’t been revealed yet. Metabolomics has become a new platform for biomarker discovery over recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tao, Hui, Ruting, Nouws, Jessica, Sauler, Maor, Zeng, Tianyang, Wu, Qingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919643/
https://www.ncbi.nlm.nih.gov/pubmed/35287685
http://dx.doi.org/10.1186/s12967-022-03311-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919643/
https://www.ncbi.nlm.nih.gov/pubmed/35287685
http://dx.doi.org/10.1186/s12967-022-03311-z

Ejemplares similares